XASX
RIC
Market cap700mUSD
Jul 10, Last price
2.75AUD
1D
2.23%
1Q
0.36%
Jan 2017
120.00%
Name
Ridley Corporation Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ridley Corporation Limited, along with its subsidiaries, stands as a prominent Australian provider of animal nutrition solutions. The company's operations are primarily categorized into two segments: Packaged Feeds and Ingredients, and Bulk Stockfeeds. It manufactures and distributes a diverse range of packaged animal feed products and nutritional supplements. These offerings encompass bagged feeds for various animals such as poultry, dairy, dogs, horses, and general lifestyle animals, in addition to block and loose lick supplements. Specialized aquafeed, including extruded and steam-pelleted varieties for fin fish and prawns, also forms part of its portfolio. Its operations further extend to rendered products from poultry, red meat, and fish, which are utilized across the pet food, stockfeed, and aquaculture sectors. The company provides monogastric and ruminant feeds—such as pellets, meals, concentrates, and premixes—tailored for poultry, pigs, dairy and beef cattle, and sheep. Ridley serves a wide spectrum of clients, from major food producers in the dairy, poultry, pig, aquaculture, sheep, and beef industries, to research facilities requiring diets for laboratory animals, and retail consumers in the equine, canine, and home layer segments. Its diverse product range is marketed under prominent brands including Barastoc, Rumevite, Cobber, Primo, and Food for Dogs. The company also engages in international exports. Founded in 1987, Ridley Corporation Limited is headquartered in Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||